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Background
Llamas raise two different types of antibodies against for-
eign invaders, the conventional antibodies and the heavy
chain devoid of light chain antibodies. We have used
llama to raise and select the latter class antibodies (VHH)
against HIV-1. The advantage of using VHHs is the relative
ease to construct large (>108) and nearly 100% functional
phage libraries. Recently we have succeeded in the selec-
tion of VHHs against the CD4 binding site from a CN54
immune library. However, the attempt to select VHHs
against gp41 from this library or a gp41 peptide immune
library was not successful. Therefore, a recombinant
trimeric gp41 was used for immunization and selections
in this study.
Methods
To select VHHs that bind to the particular epitopes on
gp41, competitive elution with the neutralizing mono-
clonal antibodies 2F5 and 4E10 was used.
Results
Comparison of the amino acid sequences of the selected
VHHs with the V-, D- and J-genes on the chromosome of
llamas resulted in the identification of 12 different fami-
lies of VHHs, which bind to the 2F5/4E10 epitope. Pep-
scan analysis showed that 5 of the 10 amino acids of the
2F5 epitope were recognized by one of the selected VHHs
(2H10). Nevertheless, the selected VHHs did not give
favorable results in neutralization assay. As the antigen is
a trimer, we reasoned that bi- and/or tri-heads of VHHs
with good binding properties may provide neutralization.
Indeed the bihead of 2H10 neutralized HIV at nanomolar
concentrations.
Conclusion
We selected VHHs that bind to gp41. The amenability of
the VHHs to recombine into multivalent peptides enabled
the construction of functional bihead of VHHs. The bind-
ing affinity of the bihead increased ~ 100-folds, and more
importantly, the bihead achieved neutralization of HIV.
This shows again that llama VHHs are a versatile tool in
targeting the difficult HIV infection mechanism.
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